Ectonucleotidase-Mediated Suppression of Lupus Autoimmunity and Vascular Dysfunction

Abstract

These data are the first to link ectonucleotidases with lupus autoimmunity and vascular disease. New therapeutic strategies may harness purinergic nucleotide dissipation or signaling to limit the damage inflicted upon organs and blood vessels by lupus.